Furthermore, basal activity of p52 in primary CLL cells (as measured by ELISA) correlated with sensitivity to CW15337 (Figure 3D), suggesting that cells with higher nuclear p52, including those carrying NOTCH1 or BIRC3 mutations, are more sensitive to NIK inhibition. This evidence concerns the gene BIRC3 and B-cell chronic lymphocytic leukemia.